Stryker to invest about $225M in RD&I projects at 3 Irish facilities | Orchestra BioMed, Terumo enter $35M partnership | Acumed buys Radicle's wrist repair system
June 14, 2019
ADVAMED SmartBrief
News for medical technology professionals
Top Story
Stryker to invest about $225M in RD&I projects at 3 Irish facilities
Stryker has announced research, development and innovation investments worth around $225 million in three of its Irish facilities. The company's instruments innovation center, AMagine Institute and neurovascular business will see the investments.
BreakingNews (Ireland) (6/13) 
LinkedIn Twitter Facebook Email
Business & Market Trends
Orchestra BioMed, Terumo enter $35M partnership
Orchestra BioMed and Tokyo-based Terumo have teamed up on the development and commercialization of Orchestra's Virtue sirolimus-eluting balloon in peripheral cardiovascular and coronary interventions. Terms of the agreement include the payment of $30 million upfront and a $5 million equity commitment plus potential milestone payments from Terumo to Orchestra.
FierceBiotech (6/13) 
LinkedIn Twitter Facebook Email
Acumed buys Radicle's wrist repair system
Acumed has paid an undisclosed amount for Radicle Orthopaedics' RASL Repair System, a device intended for treating the scapholunate ligament in the wrist. The acquisition is intended to expand Acumed's hand and wrist portfolio, which includes the the Acutrak 2 Headless Compression Screw.
Becker's Spine Review (6/13) 
LinkedIn Twitter Facebook Email
Zimmer Biomet appoints chief medical officer
Zimmer Biomet has tapped orthopedic surgeon Andrew Freiberg to serve as its chief medical officer, a newly created position in the company. Freiberg, an adult reconstructive surgery expert with a focus on hip and knee arthroplasty, has led Massachusetts General Hospital's hip and knee service for more than two decades.
Orthopedics This Week (6/13) 
LinkedIn Twitter Facebook Email
New oncology informatics president named by Elekta
Sukhveer Singh has been appointed president of oncology informatics at Elekta, effective June 25. Singh has over 20 years of experience in the health care industry.
AuntMinnie (free registration) (6/13) 
LinkedIn Twitter Facebook Email
Science & Health
N.Y. health department OKs Bio-Techne's prostate cancer test
The New York State Department of Health has granted Bio-Techne a clinical laboratory permit for its liquid biopsy-based ExoDx Prostate IntelliScore test, which helps determine whether patients who have an ambiguous prostate specific antigen test result need a prostate biopsy. The test is now available in all 50 states as a result of the decision.
GenomeWeb Daily News (free registration) (6/13) 
LinkedIn Twitter Facebook Email
BD releases new infusion pump firmware to fix 2 vulnerabilities
CyberMDX researchers have found that Becton Dickinson's Alaris Gateway Workstation infusion pump could be remotely controlled by installing malicious firmware on its onboard computer, and its monitoring and configuration interfaces could also be accessed by an attacker via a web browser. The device manufacturer has advised pump owners to update the devices with the latest firmware, which comes with fixes for the two vulnerabilities.
TechCrunch (6/13) 
LinkedIn Twitter Facebook Email
Emerging Technologies
Dexcom to launch G6 diabetes system features over next year
Dexcom CEO Kevin Sayer said a number of G6 diabetes system upgrades, including a direct-to-Apple Watch version, will be released by the company throughout the next year. The company is also developing the G7 system in partnership with Alphabet subsidiary Verily and is looking to launch the G6 system to the Medicare market.
CNBC (6/13) 
LinkedIn Twitter Facebook Email
FDA clears Materialise's cardiovascular planning software
The FDA has granted Materialise clearance to market its Mimics Enlight cardiovascular planning software, which facilitates planning of transcatheter mitral valve replacement procedures by allowing the production of 3D patient-specific models.
AuntMinnie (free registration) (6/13) 
LinkedIn Twitter Facebook Email
Government & Regulatory
EU OKs eMurmur's heart murmur detection device
European regulators have granted eMurmur CE mark approval for its sensor that detects heart murmurs using machine learning, a web portal and a mobile app. The mobile device, which uses cloud technology and a third-party electronic stethoscope, also determines when a heart murmur is absent.
FDAnews (6/14) 
LinkedIn Twitter Facebook Email
AdvaMed Events and Education
Start saving with the AdvaMed Purchasing Group
The AdvaMed Purchasing Group is a new member-only benefit that helps companies purchase the very best goods and services from nationally recognized suppliers at the very best cost, using a trusted and proven vetting system and the collective purchasing power of our membership. Participation is free for AdvaMed members, and there are no minimum commitments. Get started today.
LinkedIn Twitter Facebook Email
Learn more about AdvaMed:
About AdvaMed | Join | Courses | Events | Newsroom
powered by
Associate Director, Regulatory Affairs - Global Strategic Regulatory
ABBOTT - Abbott Park, IL
Head Global Regulatory Strategy, Devices New Product Development
BAYER - Indianola, PA
[We] thought that once we'd climbed the mountain, it was unlikely anyone would ever make another attempt.
Sir Edmund Hillary,
mountaineer who, with Sherpa Tenzing Norgay, was the first climber to reach Mount Everest's summit
LinkedIn Twitter Facebook Email
Sign Up
SmartBrief offers 200+ newsletters
Learn more about the SmartBrief audience
Subscriber Tools:
Contact Us:
Jobs Contact  -
Advertising  -  Sarah Hostetler
Editor  -  April Hollis
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2019 SmartBrief, Inc.®
Privacy Policy (updated May 25, 2018) |  Legal Information